Neuronetics Balance Sheet Health

Financial Health criteria checks 5/6

Neuronetics has a total shareholder equity of $34.2M and total debt of $59.3M, which brings its debt-to-equity ratio to 173.4%. Its total assets and total liabilities are $115.8M and $81.6M respectively.

Key information

173.4%

Debt to equity ratio

US$59.28m

Debt

Interest coverage ration/a
CashUS$59.68m
EquityUS$34.19m
Total liabilitiesUS$81.64m
Total assetsUS$115.83m

Recent financial health updates

Recent updates

Even With A 26% Surge, Cautious Investors Are Not Rewarding Neuronetics, Inc.'s (NASDAQ:STIM) Performance Completely

Mar 17
Even With A 26% Surge, Cautious Investors Are Not Rewarding Neuronetics, Inc.'s (NASDAQ:STIM) Performance Completely

Neuronetics: Modest Improvements Are Not Enough

Jan 30

Neuronetics, Inc. (NASDAQ:STIM) Soars 61% But It's A Story Of Risk Vs Reward

Dec 19
Neuronetics, Inc. (NASDAQ:STIM) Soars 61% But It's A Story Of Risk Vs Reward

Neuronetics, Inc.'s (NASDAQ:STIM) Shares Not Telling The Full Story

Jun 21
Neuronetics, Inc.'s (NASDAQ:STIM) Shares Not Telling The Full Story

Does Neuronetics (NASDAQ:STIM) Have A Healthy Balance Sheet?

May 10
Does Neuronetics (NASDAQ:STIM) Have A Healthy Balance Sheet?

Neuronetics: Growth To Capture, But Fairly Priced

Sep 06

Is Neuronetics (NASDAQ:STIM) Using Debt Sensibly?

Sep 06
Is Neuronetics (NASDAQ:STIM) Using Debt Sensibly?

Neuronetics gets FDA nod for its D-Tect accessory product for use to treat depression

Aug 29

Neuronetics GAAP EPS of -$0.39 beats by $0.02, revenue of $16.3M beats by $0.84M , revises FY guidance

Aug 02

Neuronetics stock soars 30% as FDA clears NeuroStar system for anxious depression

Jul 19

Is Neuronetics (NASDAQ:STIM) A Risky Investment?

Jun 08
Is Neuronetics (NASDAQ:STIM) A Risky Investment?

Is Neuronetics (NASDAQ:STIM) Weighed On By Its Debt Load?

Jan 19
Is Neuronetics (NASDAQ:STIM) Weighed On By Its Debt Load?

Is Neuronetics (NASDAQ:STIM) Using Debt In A Risky Way?

Oct 14
Is Neuronetics (NASDAQ:STIM) Using Debt In A Risky Way?

Financial Position Analysis

Short Term Liabilities: STIM's short term assets ($93.8M) exceed its short term liabilities ($19.8M).

Long Term Liabilities: STIM's short term assets ($93.8M) exceed its long term liabilities ($61.8M).


Debt to Equity History and Analysis

Debt Level: STIM has more cash than its total debt.

Reducing Debt: STIM's debt to equity ratio has increased from 42.8% to 173.4% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: STIM has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: STIM has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 12.2% each year.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.